Now accepting Telehealth appointments. Schedule a virtual visit.

New Discovery May Help People With Chronic Pain

New Discovery May Help People With Chronic Pain

December 9, 2024
By Neurological Institute of Los Angeles (NILA)


Big News About Pain Relief

Scientists have found a new way to treat chronic pain. They discovered a natural substance called hederagenin that blocks a part of the brain and spinal cord called the NPFFR1 receptor. This receptor plays a big role in how we feel pain.

This discovery could lead to new medicines that help people with long-term pain feel better.


What You Should Know


Why This Matters

Millions of people live with chronic pain. Current treatments don’t always work well or can cause side effects. This discovery is a step toward making better and safer medicines for pain.


Teamwork Made It Happen

Researchers from different fields, like medicine and computer science, worked together to make this discovery. Professor Beck-Sickinger, one of the leaders of the project, said:
"This work shows how basic research can create new ways to help people."


What’s Next?

Scientists will keep studying hederagenin to turn this discovery into real medicines. This gives hope to many people who live with pain every day.

At NILA, we bring the latest science to help our patients. If you or someone you know struggles with chronic pain, contact us to learn about the treatments we offer.


Tags: Chronic Pain, Neuroscience, Pain Relief, NPFFR1, Hederagenin, Neurology

You Might Also Enjoy...

SUMMER HEADACHES?

SUMMER HEADACHES?

As summer approaches, many people look forward to sunny days and outdoor activities. However, the heat can also bring an unwelcome visitor: the headache. At The Nila Neurological Institute of Los Angeles, we understand how disruptive headaches can be.

New Computer Simulation Could Help Fight Brain Diseases

Scientists have developed a computer simulation that accurately mimics how neurons grow in the brain's memory center, the hippocampus. This breakthrough could help researchers better understand and treat neurodegenerative diseases like Alzheimer’s and Park